Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (101-110 of 284) with videos related to

Pageof 29
Sort By:
Frontiers in Oncology|October 25, 2023
Human antibody V<sub>H</sub> domains targeting uPAR as candidate therapeutics for cancersXiaojie Chu, Wei Li, Margaret G Hines, et al.
The Journal of Biological Chemistry|January 18, 2003
Evidence for CD4-enchanced signaling through the chemokine receptor CCR5Robert Staudinger, Sanjay K Phogat, Xiaodong Xiao, et al.
Current Drug Discovery Technologies|July 19, 2013
Discovery of novel candidate therapeutics and diagnostics based on engineered human antibody domainsWeizao Chen, Rui Gong, Tianlei Ying, et al.
Molecular Cancer Therapeutics|May 7, 2009
A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicityYang Feng, Xiaodong Xiao, Zhongyu Zhu, et al.
Journal of Virology|July 1, 2011
Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogensWeizao Chen, Yang Feng, Rui Gong, et al.
Biochemical and Biophysical Research Communications|January 10, 2012
Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogensWeizao Chen, Emily D Streaker, Daniel E Russ, et al.
Frontiers in Microbiology|August 10, 2012
Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencingPonraj Prabakaran, Zhongyu Zhu, Weizao Chen, et al.
Molecular Pharmaceutics|April 17, 2023
Human Antibody V<sub>H</sub> Domains Targeting GPNMB and VCAM-1 as Candidate Therapeutics for CancersXiaojie Chu, Wei Li, Margaret G Hines, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 31, 2015
No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging virusesDimiter S Dimitrov, Shibo Jiang, Tianlei Ying, et al.
Nature Communications|March 12, 2015
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesisWei Gao, Zhewei Tang, Yi-Fan Zhang, et al.
Pageof 29

Showing results (101-110 of 284) with videos related to

Sort By:
Pageof 29
Frontiers in Oncology|October 25, 2023
Human antibody V<sub>H</sub> domains targeting uPAR as candidate therapeutics for cancersXiaojie Chu, Wei Li, Margaret G Hines, et al.
The Journal of Biological Chemistry|January 18, 2003
Evidence for CD4-enchanced signaling through the chemokine receptor CCR5Robert Staudinger, Sanjay K Phogat, Xiaodong Xiao, et al.
Current Drug Discovery Technologies|July 19, 2013
Discovery of novel candidate therapeutics and diagnostics based on engineered human antibody domainsWeizao Chen, Rui Gong, Tianlei Ying, et al.
Molecular Cancer Therapeutics|May 7, 2009
A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicityYang Feng, Xiaodong Xiao, Zhongyu Zhu, et al.
Journal of Virology|July 1, 2011
Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogensWeizao Chen, Yang Feng, Rui Gong, et al.
Biochemical and Biophysical Research Communications|January 10, 2012
Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogensWeizao Chen, Emily D Streaker, Daniel E Russ, et al.
Frontiers in Microbiology|August 10, 2012
Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencingPonraj Prabakaran, Zhongyu Zhu, Weizao Chen, et al.
Molecular Pharmaceutics|April 17, 2023
Human Antibody V<sub>H</sub> Domains Targeting GPNMB and VCAM-1 as Candidate Therapeutics for CancersXiaojie Chu, Wei Li, Margaret G Hines, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 31, 2015
No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging virusesDimiter S Dimitrov, Shibo Jiang, Tianlei Ying, et al.
Nature Communications|March 12, 2015
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesisWei Gao, Zhewei Tang, Yi-Fan Zhang, et al.
Pageof 29